Overall, tumor-intrinsic LAG-3+ expression indicates poor response to PD-1/PD-L1 inhibitors in mTNBCs, but LAG-3+ in CK- cells, consisting of immune cells including PD-L1+ cells, results in the opposite response for PD-1/PD-L1 inhibitors. The gene discussed is LAG3; the disease is neoplasm.